Retraction: QbD-based rivastigmine tartrate-loaded solid lipid nanoparticles for enhanced intranasal delivery to the brain for Alzheimer's therapeutics.
Alzforum,
Frontiers Editorial Office. Front Aging Neurosci. 2024;16:1399271. Epub 2024 Mar 28 PubMed.